Gleason Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.9K | Buy |
91
+1
| +1% | +$186 | ﹤0.01% | 152 |
|
|
2025
Q1 | $19K | Hold |
90
| – | – | ﹤0.01% | 145 |
|
|
2024
Q4 | $15.9K | Buy |
90
+1
| +1% | +$177 | ﹤0.01% | 152 |
|
|
2024
Q3 | $17.6K | Sell |
89
-29
| -25% | -$5.72K | ﹤0.01% | 146 |
|
|
2024
Q2 | $20.3K | Buy |
118
+1
| +0.9% | +$172 | ﹤0.01% | 162 |
|
|
2024
Q1 | $21.3K | Buy |
117
+1
| +0.9% | +$182 | ﹤0.01% | 143 |
|
|
2023
Q4 | $18K | Buy |
116
+1
| +0.9% | +$155 | ﹤0.01% | 152 |
|
|
2023
Q3 | $17.1K | Buy |
115
+1
| +0.9% | +$149 | ﹤0.01% | 159 |
|
|
2023
Q2 | $15.3K | Buy |
114
+1
| +0.9% | +$134 | ﹤0.01% | 166 |
|
|
2023
Q1 | $18K | Buy |
113
+83
| +277% | +$13.2K | 0.01% | 152 |
|
|
2022
Q4 | $4.77K | Sell |
30
-123
| -80% | -$19.5K | ﹤0.01% | 192 |
|
|
2022
Q3 | $21K | Buy |
153
+126
| +467% | +$17.3K | 0.01% | 143 |
|
|
2022
Q2 | $4K | Hold |
27
| – | – | ﹤0.01% | 202 |
|
|
2022
Q1 | $4K | Hold |
27
| – | – | ﹤0.01% | 191 |
|
|
2021
Q4 | $4K | Hold |
27
| – | – | ﹤0.01% | 182 |
|
|
2021
Q3 | $3K | Buy |
27
+1
| +4% | +$111 | ﹤0.01% | 185 |
|
|
2021
Q2 | $3K | Hold |
26
| – | – | ﹤0.01% | 181 |
|
|
2021
Q1 | $3K | Hold |
26
| – | – | ﹤0.01% | 179 |
|
|
2020
Q4 | $3K | Sell |
26
-488
| -95% | -$56.3K | ﹤0.01% | 174 |
|
|
2020
Q3 | $45K | Buy |
514
+6
| +1% | +$525 | 0.03% | 95 |
|
|
2020
Q2 | $50K | Buy |
508
+6
| +1% | +$591 | 0.03% | 87 |
|
|
2020
Q1 | $38K | Buy |
502
+6
| +1% | +$454 | 0.03% | 91 |
|
|
2019
Q4 | $44K | Buy |
+496
| New | +$44K | 0.03% | 103 |
|